Buspirone: Still Effective After All These Years?
The Carlat Psychiatry Report, Volume 19, Number 2, February 2021
https://www.thecarlatreport.com/newsletter-issue/tcprv19n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Anxiety | Anxiety Disorder | Benzodiazepines | Buspirone | GAD | Generalized Anxiety Disorder | Lavender | Medication | Melatonin | Pharmacology | Pregnancy | Psychopharmacology | Silexan
Eugene Rubin, MD.
Psychiatrist in private practice, Bingham Farms, MI.
Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Buspirone (Buspar) is approved for generalized anxiety disorder, but its efficacy there is often questioned. Here we find out how it stacks up against the benzos and SSRIs, and explore its off-label potential in depression, sexual dysfunction, alcoholism, traumatic brain injury, and premenstrual dysphoric disorder.
You can't view details of this content, please login or buy subscription here